Pfizer’s twice-daily weight loss pill joins a long list of obesity drug flops
Before successful weight loss treatments such as Wegovy and Ozempic, the pharmaceutical path to treating obesity was strewn with failures dating back decades.
Similar Posts
NASA to train Indian astronaut for ISS voyage in deepening space ties
Post Content Post Views: 73
Sunlands Technology GAAP EPS of $2.62, revenue of $71.9M; initiates Q4 outlook
Post Content Post Views: 92
Zen Technologies shares rise 4% on new ₹42 crore defence contract
Post Content Post Views: 112
Gazprom to cut capital investments in 2024, focuses on strategic projects
Post Content Post Views: 76
Gold prices race to near 7-mth high on dovish Fed speak
Post Content Post Views: 79
iRobot shares close up 39% on report Amazon deal set to get EU approval
Shares of iRobot, the maker of Roomba vacuums, closed up about 39% Friday after a report said the European Union is set to approve Amazon’s acquisition. Post Views: 75